Literature DB >> 11750869

Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro.

I P Crocker1, B K Strachan, G E Lash, S Cooper, A Y Warren, P N Baker.   

Abstract

OBJECTIVE: The object of this study was to determine the effect of epithelial growth factor (EGF), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) on the differentiation of first-trimester and term cytotrophoblasts.
METHODS: The first-trimester trophoblasts were isolated from villous tissue obtained at suction termination (n = 5), and the term trophoblasts were isolated from placentas (n = 6) at elective cesarean. Cultured cells were stimulated with EGF, VEGF, or PlGF at 0.5, 5, and 50 ng/mL, in the presence or absence of N(G)-nitro-L-arginine methyl ester hydrochloride (10(-4) M). Syncytialized trophoblasts were identified by immunostaining with antidesmosomal protein and anti-cytokeratin-7, whereas nuclei were counted in each syncytia using hematoxylin.
RESULTS: Without treatment, background levels of syncytialization were significantly higher in term preparations than first-trimester cells. With VEGF and EGF, the number and size of syncytia increased significantly for the first-trimester cytotrophoblasts (P <.05). Neither VEGF nor EGF had any effect on the syncytialization of cultured cells at term. Nitric oxide showed no involvement in syncytial induction, and PlGF had no effect on syncytialization of cytotrophoblasts, from either the first or third trimester.
CONCLUSION: Both EGF and VEGF appeared to enhance the in vitro syncytialization of first trimester cytotrophoblasts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750869

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  9 in total

Review 1.  Hormones and human trophoblast differentiation: a review.

Authors:  André Malassiné; Laurent Cronier
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction.

Authors:  Ian P Crocker; Suzanne Cooper; Stephen C Ong; Philip N Baker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

3.  Biochemical markers for prediction of preclampsia: review of the literature.

Authors:  Santo Monte
Journal:  J Prenat Med       Date:  2011-07

4.  Expression of uPAR in human trophoblast and its role in trophoblast invasion.

Authors:  Shuai Liu; Qin Zheng; Xin-Yuan Cui; Kui-Xing Dai; Xue-Song Yang; Fa-Sheng Li; Qiu Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Morphological and phenotypic analyses of the human placenta using whole mount immunofluorescence.

Authors:  Meghan E Bushway; Scott A Gerber; Bruce M Fenton; Richard K Miller; Edith M Lord; Shawn P Murphy
Journal:  Biol Reprod       Date:  2014-03-19       Impact factor: 4.285

6.  HCG-Activated Human Peripheral Blood Mononuclear Cells (PBMC) Promote Trophoblast Cell Invasion.

Authors:  Nan Yu; Wenjie Yan; Tailang Yin; Yaqin Wang; Yue Guo; Danni Zhou; Mei Xu; Jinli Ding; Jing Yang
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 7.  PPARγ-A Factor Linking Metabolically Unhealthy Obesity with Placental Pathologies.

Authors:  Sebastian Kwiatkowski; Anna Kajdy; Katarzyna Stefańska; Magdalena Bednarek-Jędrzejek; Sylwia Dzidek; Piotr Tousty; Małgorzata Sokołowska; Ewa Kwiatkowska
Journal:  Int J Mol Sci       Date:  2021-12-06       Impact factor: 5.923

Review 8.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

9.  The proprotein convertase furin is required for trophoblast syncytialization.

Authors:  Z Zhou; Q Zhang; X Lu; R Wang; H Wang; Y-L Wang; C Zhu; H-Y Lin; H Wang
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.